No deleterious germline BRCA1 or BRCA2 mutation based on full sequencing and comprehensive rearrangement testing at an external reference laboratory (Myriad Genetics); patients with variants of unknown significance will be eligible [clinicaltrials_resource:18269f8919363ff53b6464b34c1b440b]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
No deleterious germline BRCA1 or BRCA2 mutation based on full sequencing and comprehensive rearrangement testing at an external reference laboratory (Myriad Genetics); patients with variants of unknown significance will be eligible [clinicaltrials_resource:18269f8919363ff53b6464b34c1b440b]
Bio2RDF identifier
18269f8919363ff53b6464b34c1b440b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:18269f8919363ff53b6464b34c1b440b
identifier
clinicaltrials_resource:18269f8919363ff53b6464b34c1b440b
title
No deleterious germline BRCA1 ...... significance will be eligible
@en
type
label
No deleterious germline BRCA1 ...... 69f8919363ff53b6464b34c1b440b]
@en